Infant onset severe complement-mediated hemolytic uremic syndrome complicated by secondary sclerosing cholangitis

J Clin Apher. 2018 Oct;33(5):619-623. doi: 10.1002/jca.21651. Epub 2018 Aug 30.
No abstract available

Keywords: eculizumab, secondary sclerosing cholangitis; hemolytic uremic syndrome; therapeutic plasma exchange.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / pharmacology
  • Atypical Hemolytic Uremic Syndrome / complications*
  • Atypical Hemolytic Uremic Syndrome / therapy
  • Cholangitis, Sclerosing / etiology*
  • Cholangitis, Sclerosing / therapy
  • Complement Factor H
  • Complement Inactivating Agents / pharmacology
  • Humans
  • Infant
  • Plasma Exchange / methods

Substances

  • Antibodies, Monoclonal, Humanized
  • Complement Inactivating Agents
  • Complement Factor H
  • eculizumab